A typical neurofibromatosis type 1 in adult with intracranial T2 hyperintensities and pinealoma: A Case Report

Main Article Content

Siwei Chen
Haiqiang Jin
Jing Bai
Wei Zhang
Jingjing Luo
Yining Huang
Yongan Sun*

Abstract

Neurofibromatosis type 1 (NF-1) is a common autosomal dominant inherited disorder. Aside from typical symptoms like pigmentary manifestation, patients with NF-1 can also have unspecified T2 hyperintensities (T2Hs) on the brain and may develop benign or malignant tumours in central nervous system or other parts of the body. In this article, we reported a 54-year-old female diagnosed as NF-1 combined with T2Hs and pinealoma that was proved to be a high-grade glioma in later follow-up. We noticed some clinical manifestations such as pigmented teeth and dentition defects that had not been described before. There were some reflections from the poor prognosis of this patient. Even though the course of the disease is relatively indolent most of the time, long-term surveillance is in need and treatment may be required in those with symptoms or unstable imaging findings.

Downloads

Download data is not yet available.

Article Details

Chen, S., Jin, H., Bai, J., Zhang, W., Luo, J., Huang, Y., & Sun, Y. (2020). A typical neurofibromatosis type 1 in adult with intracranial T2 hyperintensities and pinealoma: A Case Report. Global Journal of Medical and Clinical Case Reports, 7(1), 022–023. https://doi.org/10.17352/2455-5282.000085
Case Reports

Copyright (c) 2020 Chen S, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13: 834-843. Link: https://bit.ly/3bIF4Yc

Listed N (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45: 575-578. Link: https://bit.ly/3bDUBbs

Friedrich RE, Reul A (2017) Supernumerary Molars and Wisdom Tooth Shape Alterations in Patients with Neurofibromatosis Type 1. J Oral Maxillofac Res 8: e5. Link: https://bit.ly/3cPtieK

Tucker T, Schnabel C, Hartmann M, Friedrich RE, Frieling I, et al. (2009) Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet 46: 259-265. Link: https://bit.ly/3aCRyPm

Griffith JL, Jasia MS, Mahdi J, Goyal SM, Hershey et al. (2018) Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1. Neuro Clin Pract 8: 283-291. Link: https://bit.ly/2yLfIu8

Helfferich J, Nijmeijer R, Brouwer OF, Boon M, Fock A, et al. (2016) Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas. Crit Rev Oncol Hematol 104: 30-41. Link: https://bit.ly/3eRIn0P

Wong TT, Ho DM, Chang TK, Yang DD, Lee LS (1995) Familial neurofibromatosis 1 with germinoma involving the basal ganglion and thalamus. Childs Nerv Syst 11: 456-468. Link: https://bit.ly/2KA1j6o

Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, et al. (2006) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44: 81-88. Link: https://bit.ly/2Y3TXjF

Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L (2007) Brainstem Lesions in Neurofibromatosis Type 1. Neurosurgery. 61: 762-767. Link: https://bit.ly/2W2RrYu